Dexlansoprazole
Gastroesophageal Reflux Disease
National Cheng-Kung University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Gastroesophageal Reflux Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lansoprazole Children's Mercy Hospital Kansas City | Phase 4 | BB |
PANTOPRAZOLE Children's Mercy Hospital Kansas City | Phase 4 | BB |
MIDAZOLAM Children's Mercy Hospital Kansas City | Phase 4 | BB |
TANNIC ACID Hospital Infantil Cândido Fontoura | Phase 3 | BB |
LIDOCAINE Hospital Infantil Cândido Fontoura | Phase 3 | BB |
View all 17 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →